搜索
Accuray Inc
ARAY添加自选
0.260USD
+0.002+0.66%
收盘 07/01, 16:00（美东）报价延迟15分钟
30.86M总市值
亏损市盈率 TTM
关键数据
0.259今开
0.267最高
2.00M成交量
亏损市盈率 TTM
亏损市盈率动
--股息TTM
1.68%换手率
0.258昨收
0.255最低
431.84K成交额
亏损市盈率静
0.74市净率
0.00%股息率 TTM
-9.90%ROA
2.10052周最高
0.53量比
-1.59M净利润
118.93M总股本
-0.3780每股收益TTM
1.34Beta
-101.06%ROE
0.33052周最低
4.38%振幅
23.76%毛利率
30.86M总市值
-6.30回报/风险
5.60%风险率
TradingKey Accuray Inc股票评分
单位: USD 更新时间: 2026-07-01操作建议
Accuray Inc当前公司基本面数据相对稳定，增长潜力很大。当前估值合理，在医疗设备与耗材行业排名107/204位。机构持股占比非常高，近一月多位分析师给出公司评级为持有。最高目标价0.35。中期看，股价处于下降通道。近一个月，市场表现非常差，但基本面评分较高。目前股价在压力位和支撑位之间，可以做区间波段操作。
Accuray Inc评分
压力支撑
由于公司未披露，未能获取相关数据
多维评测
本期评分
上期评分
公司舆情
过去24小时
热度
过冷
过热
看空
Accuray Inc亮点
亮点风险
Accuray Incorporated is a radiation therapy company. The Company develops, manufactures, sells and supports solutions that are designed to deliver radiation treatments for complex cases. Its solutions are designed to advance patient care: during each individual treatment, throughout the treatment process, and at each stage of the cancer treatment journey, from curative to palliative treatments. Its technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, its TomoTherapy platform, are designed to deliver advanced treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and adaptive radiation therapy (ART). In addition to these products, it also provides services, which include post-contract customer support (warranty period services and post-warranty services), installation services, training, and other professional services.
估值高估
公司最新PE估值-0.69，处于3年历史高位
机构减仓
最新机构持股85.92M股，环比减少3.71%
ETHSX持仓
明星投资者ETHSX持仓，最新持仓市值2.71K
活跃度降低
近期活跃度降低，过去20天平均换手率0.71
分析师目标
根据
2
位分析师
持有
评级
0.350
目标均价
+35.76%
涨幅空间
Accuray Inc新闻
即将为您带来更多新闻，敬请期待。。。
财务指标
每股收益
由于公司未披露，未能获取相关数据
营业总收入
由于公司未披露，未能获取相关数据
Accuray Inc简介
Accuray Incorporated is a radiation therapy company. The Company develops, manufactures, sells and supports solutions that are designed to deliver radiation treatments for complex cases. Its solutions are designed to advance patient care: during each individual treatment, throughout the treatment process, and at each stage of the cancer treatment journey, from curative to palliative treatments. Its technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, its TomoTherapy platform, are designed to deliver advanced treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and adaptive radiation therapy (ART). In addition to these products, it also provides services, which include post-contract customer support (warranty period services and post-warranty services), installation services, training, and other professional services.
公司代码ARAY
公司Accuray Inc
CEOLa Neve (Stephen R)
网址https://www.accuray.com/
相关品种
+2.62%
+2.41%
+1.57%
+1.18%
+1.73%
+1.30%
-0.50%
+1.27%
+7.60%
+0.88%
+0.39%
+0.89%
+1.92%
+1.70%
+3.09%
+2.12%
+1.08%
+1.78%
+0.41%
+0.78%热门品种
常见问题
Accuray Inc(ARAY)的当前股价是多少？
Accuray Inc(ARAY)的当前股价是 0.26。
Accuray Inc的股票代码是什么？
Accuray Inc的股票代码是ARAY。
Accuray Inc股票的52周最高点是多少？
Accuray Inc股票的52周最高点是2.10。
Accuray Inc股票的52周最低点是多少？
Accuray Inc股票的52周最低点是0.33。
Accuray Inc的市值是多少？
Accuray Inc的市值是30.86M。
现在Accuray Inc(ARAY)的股票是买入、持有还是卖出？
根据分析师评级，Accuray Inc(ARAY)的总体评级为signal_hold，目标价格为0.35。
Accuray Inc(ARAY)股票的每股收益（EPS TTM）是多少
Accuray Inc(ARAY)股票的每股收益（EPS TTM）是-0.02。